Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis

Inhibition of the renin-angiotensin-aldosterone system (RAAS) is broadly recommended in many nephrological guidelines to prevent chronic kidney disease (CKD) progression. This work aimed to analyze the robustness of randomized controlled trials (RCTs) investigating the renal and cardiovascular outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Capuano, Ivana, Buonanno, Pasquale, Riccio, Eleonora, Bianco, Antonio, Pisani, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605379/
https://www.ncbi.nlm.nih.gov/pubmed/36294504
http://dx.doi.org/10.3390/jcm11206184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605379/
https://www.ncbi.nlm.nih.gov/pubmed/36294504
http://dx.doi.org/10.3390/jcm11206184

Ejemplares similares